Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Phase II, multicenter, open-label, multi-cohort proof-of-concept study designed to evaluate the safety and efficacy of Ezabenlimab combined with BI 907828 in patients with unresectable, locally advanced or metastatic solid tumors.
创建时间：
2024-01-15
